NCT06880250View on ClinicalTrials.gov

Efficacy and Safety of Enzyme Replacement Therapy in Patients with Fabry Disease

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Fabry Disease

All Listed Sponsors

lead

NPO Petrovax

INDUSTRY

NCT06880250 - Efficacy and Safety of Enzyme Replacement Therapy in Patients with Fabry Disease | Biotech Hunter | Biotech Hunter